Tiziana Romanazzi

Dr. Tiziana Romanazzi

University of Insubria, Varese, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Open access
MBManan Bhatt
Manan Bhatt
AIAngela Di Iacovo
Angela Di Iacovo
TRTiziana Romanazzi
Tiziana Romanazzi
CRCristina Roseti
Cristina Roseti
Elena BossiElena Bossi
Elena Bossi
The role of betaine in the liver and kidney has been well documented, even from the cellular and molecular point of view. Despite literature reporting positive effects of betaine supplementation in Alzheimer's, Parkinson's and schizophrenia, the role and function of betaine in the brain are little studied and reviewed. Beneficial effects of betaine in neurodegeneration, excitatory and inhibitory imbalance and against oxidative stress in the central nervous system (CNS) have been collected and analysed to understand the main role of betaine in the brain. There are many ‘dark’ aspects needed to complete the picture. The understanding of how this osmolyte is transported across neuron and glial cells is also controversial, as the expression levels and functioning of the known protein capable to transport betaine expressed in the brain, betaine‐GABA transporter 1 (BGT‐1), is itself not well clarified. The reported actions of betaine beyond BGT‐1 related to neuronal degeneration and memory impairment are the focus of this work. With this review, we underline the scarcity of detailed molecular and cellular information about betaine action. Consequently, the requirement of detailed focus on and study of the interaction of this molecule with CNS components to sustain the therapeutic use of betaine.

25 September 2022 in Membranes
Verified
Journal Article
Open access
PDF file
MBManan Bhatt
Manan Bhatt
AIAngela Di Iacovo
Angela Di Iacovo
TRTiziana Romanazzi
Tiziana Romanazzi
CRCristina Roseti
Cristina Roseti
RCRaffaella Cinquetti
Raffaella Cinquetti
Elena BossiElena Bossi
Elena Bossi
After 50 years, the heterologous expression of proteins in Xenopus laevis oocytes is still essential in many research fields. New approaches and revised protocols, but also classical methods, such as the two-electrode voltage clamp, are applied in studying membrane transporters. New and old methods for investigating the activity and the expression of Solute Carriers (SLC) are reviewed, and the kinds of experiment that are still useful to perform with this kind of cell are reported. Xenopus laevis oocytes at the full-grown stage have a highly efficient biosynthetic apparatus that correctly targets functional proteins at the defined compartment. This small protein factory can produce, fold, and localize almost any kind of wild-type or recombinant protein; some tricks are required to obtain high expression and to verify the functionality. The methodologies examined here are mainly related to research in the field of membrane transporters. This work is certainly not exhaustive; it has been carried out to be helpful to researchers who want to quickly find suggestions and detailed indications when investigating the functionality and expression of the different members of the solute carrier families.

13 January 2023 in Science Advances
Verified
Journal Article
Closed access
ASAparna Shekar
Aparna Shekar
SMSamuel J. Mabry
Samuel J. Mabry
MCMary H. Cheng
Mary H. Cheng
JAJenny I. Aguilar
Jenny I. Aguilar
SPShalin Patel
Shalin Patel
AGAurelio Galli
Aurelio Galli
Amphetamine (AMPH) is a psychostimulant that is commonly abused. The stimulant properties of AMPH are associated with its ability to increase dopamine (DA) neurotransmission. This increase is promoted by nonvesicular DA release mediated by reversal of DA transporter (DAT) function. Syntaxin 1 (Stx1) is a SNARE protein that is phosphorylated at Ser 14 by casein kinase II. We show that Stx1 phosphorylation is critical for AMPH-induced nonvesicular DA release and, in Drosophila melanogaster , regulates the expression of AMPH-induced preference and sexual motivation. Our molecular dynamics simulations of the DAT/Stx1 complex demonstrate that phosphorylation of these proteins is pivotal for DAT to dwell in a DA releasing state. This state is characterized by the breakdown of two key salt bridges within the DAT intracellular gate, causing the opening and hydration of the DAT intracellular vestibule, allowing DA to bind from the cytosol, a mechanism that we hypothesize underlies nonvesicular DA release.

9 September 2025 in Science Signaling
Verified
Journal Article
Closed access
SMSamuel J. Mabry
Samuel J. Mabry
XCXixi Cao
Xixi Cao
YZYanqi Zhu
Yanqi Zhu
CRCaleb Rowe
Caleb Rowe
SPShalin Patel
Shalin Patel
AGAurelio Galli
Aurelio Galli
Amphetamines are psychostimulants that are commonly used to treat neuropsychiatric disorders and are prone to misuse. The pathogenesis of amphetamine use disorder (AUD) is associated with dysbiosis (an imbalance in the body’s microbiome) and bacterially produced short-chain fatty acids (SCFAs), which are implicated in the gut-brain axis. Amphetamine exposure in both rats and humans increases the amount of intestinal Fusobacterium nucleatum , which releases SFCAs. Here, we found that colonization of gnotobiotic Drosophila melanogaster with F. nucleatum or supplementing the flies’ diet with the SCFA butyrate enhanced the psychomotor and reward properties of amphetamine. Butyrate inhibits histone deacetylases (HDACs), and knockdown of HDAC1 recapitulated the effects induced by F. nucleatum or butyrate. The enhancement in amphetamine-induced behaviors was mediated by an increase in the amount of released dopamine that resulted from amphetamine-induced reversal of dopamine transporter (DAT) function, termed nonvesicular dopamine release (NVDR). The magnitude of amphetamine-induced NVDR was partially mediated by an increase in DAT abundance stimulated at a transcriptional level, and the administration of F. nucleatum or butyrate enhanced NVDR by increasing DAT expression. The findings indicate that F. nucleatum supports AUD through epigenetic regulation of dopamine signaling and identify potential targets for AUD treatment.

29 July 2026 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
AIAngela Di Iacovo
Angela Di Iacovo
CDChiara D’AGostino
Chiara D’AGostino
GCGiulia Casoli
Giulia Casoli
TRTiziana Romanazzi
Tiziana Romanazzi
Elena BossiElena Bossi
Elena Bossi
CRCristina Roseti
Cristina Roseti
Precise control of membrane protein localization and turnover is essential for synaptic function and circuit stability. Disruption of these processes alters the surface expression of receptors and transporters, ultimately impacting the excitatory/inhibitory (E/I) balance. Leucine-rich repeat kinase 2 (LRRK2) is emerging as a key regulator of these membrane-associated processes, acting at the interface between intracellular trafficking and synaptic signaling. LRRK2 integrates kinase activity with scaffolding functions to coordinate Rab-dependent vesicular trafficking, endosomal recycling, cytoskeletal dynamics, and endolysosomal pathways. Through these mechanisms, it controls the surface expression and distribution of synaptic receptors and neurotransmitter transporters in both neuronal and glial compartments. Pathogenic LRRK2 variants associated with Parkinson’s disease (PD), converge on kinase hyperactivation and lead to sustained alterations in trafficking networks, resulting in selective mislocalization of membrane proteins. In this review, we examine how LRRK2-dependent trafficking mechanisms regulate key components of synaptic transmission, including glutamatergic and GABAergic receptors, as well as astrocytic transporters. We highlight how disruption of these processes affects neurotransmitter clearance, receptor activation, and ultimately E/I balance. Notably, accumulating evidence indicates that LRRK2 functions as an upstream coordinator of membrane organization at the crossroads of synaptic signaling and neurotransmitter homeostasis. Understanding how LRRK2 regulates trafficking pathways across cellular compartments provides mechanistic insight into circuit vulnerability in PD and highlights membrane-targeted strategies as potential approaches for restoring synaptic stability. Graphical Abstract LRRK2 in Synaptic Communication. LRRK2 acts as a central regulator of membrane trafficking in neurons and astrocytes. Through control of vesicular pathways, cytoskeletal dynamics, and endolysosomal function, LRRK2 modulates synaptic receptors and neurotransmitter transporters, contributing to excitatory/inhibitory balance. Pathogenic variants disrupt these processes, promoting synaptic dysfunction and circuit instability